A GLOBAL LEADER IN CANNABIS GENETICS
“IF YOU WANT IT – WE CAN MAKE IT”
WE HAVE AN EXTREMELY VALUABLE AND EXPANDING LIBRARY
OF UNIQUE AND AWARD-WINNING CANNABIS STRAINS
THROUGH OUR GROUNDBREAKING TECHNOLOGIES, WE ARE POISED TO CREATE A WEALTH OF CUSTOM BESPOKE PRODUCT OPPORTUNITIES
WE HAVE A UNIQUE BUSINESS STRATEGY TO EXPAND OUR OPERATIONS INTO NEW MARKETS
MMGenetics can offer our clients a unique menu of cannabinoids and terpenes.
With over 30 years of research experience in genetic architecture, we are experts in minor cannabinoids with our focus on pushing the boundaries in research and development
Exact chemistry profiles reduce cost in downstream processing
Our genetic library provides minor cannabinoid and terpenes in exclusive ratios designed to provide a bespoke and accurate composition
CREATING GENETIC EXCELLENCE
Intellectual property includes over 100 genetic lines with lineage traceability
We have achieved a 100% germination rate for our established seed lines
Robust response to multiple propagation environments including indoor, greenhouse and outdoor cultivation
Multiple awards including six Spannabis Champions Cups* for CBD strains
PROVEN SUCCESS CD-1
Highest known consistent ratios in a CBD-rich seed strain ever created in Europe to date
Additional 12 elite strains using CD-1 as a parent
Independent lab assessments lead selection
Two dominant phenotypes allow flexibility
Grown in a GMP facility, cannabinoid levels remain high and consistent
IMPRESSIVE TRACK RECORD
Winner of 6 Spannabis Champions Cups
Our team of genetics experts, collectively, have won 50+ cannabis-related awards
(*) The Spannabis Champions Cup is the most recognised breeders award in Europe. In 2017, MMG was the first seed company in history to claim three cups concurrently.
EXPERT ADVISORY BOARD
Owen Van Cauwenberghe, PhD – Founding partner, President and COO of Bio Therapeutic Molecules Inc., Adjunct Associate Professor in the Waterloo School of Pharmacy, former Chief Research Officer at AgMedica Bioscience Inc., former Director at Accucaps Industries Ltd. and former Director, Principal Research Scientist at Eli Lilly Canada. Previously a member of the Board of Directors at MedC Biopharma.
Barry Shelp, PhD – Founding partner, Director of Bio Therapeutic Molecules Inc., Professor Emeritus and Adjunct Professor, University of Guelph, Co-founder and Director of Current Water Technologies Inc., former advisor to AgMedica Bioscience Inc. Primary research focused on various strategies concerned with developing abiotic and biotic stress resistance in plants using genetic engineering strategies. In 2015 was awarded the Gold Medal by the Canadian Society for Plant Biologists for outstanding published contributions and for distinguished service to plant biology.
Vince Quiquero, PhD – Founding partner, Director of Bio Therapeutic Molecules Inc., former Chief Scientific Officer at AgMedica Bioscience Inc., former Executive Vice President of Research and Development at Accucaps Industries Ltd., former Associate Director at Eli Lilly Canada and formerly held various positions of increasing responsibility at GlaxoSmithKline. Previously a member of the Board of Directors at Herbolea Biotech.
Adrian Burruezo – PhD Genetics and Plant Breeding ETSIAMN, Universitat Politècnica de València COMAV Institute. More than 20 years of experience in plant breeding and genetics. Enhancement of quality traits (bioactive compounds, antioxidants, volatiles, aroma, taste and flavour compounds), phylogenetic studies incrop species, genome wide association, gene expression, use of germplasm diversity for adaptation to low input conditions, organic agriculture and consumers preferences
In MMG, Agmedica has found an exceptional partner driven by the optimal mix of passion, expertise and quality one needs to compete and prosper in the new cannabis economy. Their knowledge of genetics, breeding and strain slection has definitely provided Agmedica a distinct advantage in both the medicinal and recreational space.
Ag Medica CEO
From day one, MMG has been great to work with, they have an incredible and knowledgeable team that has always gone above and beyond to help us. They have provided great suggestions for new strains and marketplace perspective. Their latest strain that we have grown has done incredibly well in our indoor facility, large firm dense flowers with great trichomes. We are very happy to be working together with MMG and look forward to a long relationship together.
Ag Medica COO
As a company that develops precisely formulated medications from cannabis, we can only with the best in the industry. MMGenetics meets reliability, quality, responsiveness and consistency with precision. Ben, Ricardo and Seve run a superb company exhibiting the highest of our industry’s standards.
Chairman and Interim CEO MedC
Founder / Chief Strategy
An experienced cannabis private investor, who has been investing in European legal cannabis start ups since 2014 after a number of years spent researching and networking across the sector. He brings knowledge, experience and a strong network in Europe and globally.
Founder / Chief Research Officer
+30 years breeding experience. He worked as Master Breeder and R&D researcher for the most important Spanish, and Dutch Seed Banks leaders.Winner of more than 20 cannabis awards including Spannabis Champions Cup.
Hands-on entrepreneur, and business leader, with more than 15 years of experience in Corporate Development and Strategy functions in large European Corporations. Senior leadership roles in International Market development.Founder of Meteo 273º , first worldwide Social Media Network focused on meteorology.